OTC Pharmaceuticals - Ireland

  • Ireland
  • Revenue in the OTC Pharmaceuticals market amounts to US$360.20m in 2024. The market is expected to grow annually by 3.59% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$86.63m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$70.77 are generated in 2024.
  • In the OTC Pharmaceuticals market, 19.1% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Ireland has experienced significant growth in recent years, driven by changing customer preferences and trends in the market. Customer preferences in Ireland have shifted towards self-care and self-medication, with consumers increasingly seeking out OTC products for minor ailments and healthcare needs.

This trend is driven by several factors, including convenience, cost-effectiveness, and a desire for greater control over one's own health. As a result, there has been a growing demand for OTC pharmaceuticals in Ireland, with consumers actively seeking out these products in pharmacies and retail stores. In addition to changing customer preferences, there are several trends in the OTC Pharmaceuticals market in Ireland that are contributing to its development.

One such trend is the increasing availability and accessibility of OTC products. Pharmacies and retail stores have expanded their product offerings, making a wider range of OTC pharmaceuticals readily available to consumers. This trend is also supported by advancements in technology, with online platforms and e-commerce making it easier for consumers to access and purchase OTC products.

Another trend in the market is the growing emphasis on preventive healthcare. Consumers in Ireland are becoming more proactive in managing their health and are seeking out OTC products that can help prevent illness and maintain overall well-being. This trend is reflected in the increasing demand for vitamins, dietary supplements, and other preventive healthcare products in the OTC Pharmaceuticals market.

Local special circumstances in Ireland also play a role in the development of the OTC Pharmaceuticals market. The country has a well-established healthcare system, with a high level of healthcare infrastructure and access to healthcare professionals. This enables consumers to make informed decisions about their healthcare needs and choose appropriate OTC products.

Additionally, Ireland has a strong pharmaceutical industry, with several multinational companies operating in the country. This local expertise and presence contribute to the availability and quality of OTC pharmaceuticals in the market. Underlying macroeconomic factors also influence the development of the OTC Pharmaceuticals market in Ireland.

The country has a stable economy and a high standard of living, which allows consumers to allocate a portion of their disposable income towards healthcare and wellness products. Additionally, the aging population in Ireland is driving demand for OTC pharmaceuticals, as older individuals often have a greater need for self-care and preventive healthcare. Overall, the OTC Pharmaceuticals market in Ireland is developing due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

As consumers in Ireland increasingly prioritize self-care and preventive healthcare, the demand for OTC pharmaceuticals is expected to continue to grow in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)